First Niagara Bank’s ResMed RMD Stock Holding History

First Niagara Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,060	Closed	-$220K	–	243
2015 Q1	$220K	Buy	+3,060	New	+$199K	0.05%	215

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Niagara Bank's RMD Position: Q2 2015 in Review

First Niagara Bank sold out of ResMed (RMD) in Q2 2015, closing a stake of 3,060 shares — an estimated $220K sold.

First Niagara Bank first reported a position in RMD in Q1 2015 and held it in 1 quarter. The position peaked at $220K in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

First Niagara Bank reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
First Niagara Bank sold 3,060 ResMed shares in Q2 2015, an estimated $220K.
First Niagara Bank first reported a position in ResMed in Q1 2015 and held it in 1 quarter.
First Niagara Bank's ResMed position peaked at $220K in Q1 2015.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on First Niagara Bank's 13F filing for Q2 2015, filed 12 Aug 2015.